MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1

Oncogene

Volumn 33, Issue 6, 2014, Pages 783-793

  Li, T ^a   Lu, Y Y ^a   Zhao, X D ^a   Guo, H Q ^a   Liu, C H ^a   Li, H ^a   Zhou, L ^a   Han, Y N ^a   Wu, K C ^a   Nie, Y Z ^a   Shi, Y Q ^a   Fan, D M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; CDX1; gastric cancer; miR 296 5p; proliferation

Indexed keywords

APOPTOSIS; CELL GROWTH PROCESSES; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84893813871     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.637     Document Type: Article

References (48)

1. DM P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. LAUREN P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
3. You WC, Li JY, Blot WJ, Chang YS, Jin ML, Gail MH et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999; 83: 615-619.
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
5. Camilo V, Barros R, Sousa S, Magalhães AM, Lopes T, Má rio Santos A et al. Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells. Carcinogenesis 2012; 33: 1985-1992.
6. Ito K, Chuang LS, Ito T, Chang TL, Fukamachi H, Salto-Tellez M et al. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology 2011; 140: 1536-1546e8.
7. Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000; 119: 961-971.
8. Mutoh H, Sakurai S, Satoh K, Osawa H, Hakamata Y, Takeuchi T et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004; 53: 1416-1423.
9. Johnstone CN, White SJ, Tebbutt NC, Clay FJ, Ernst M, Biggs WH et al. Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression. J Biol Chem 2002; 277: 34531-34539.
10. Chan CW, Wong NA, Liu Y, Bicknell D, Turley H, Hollins L et al. Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci USA 2009; 106: 1936-1941.
11. Mallo GV, Rechreche H, Frigerio JM, Rocha D, Zweibaum A, Lacasa M et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997; 74: 35-44.
12. Suh ER, Ha CS, Rankin EB, Toyota M, Traber PG. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J Biol Chem 2002; 277: 35795-35800.
13. Wong NA, Britton MP, Choi GS, Stanton TK, Bicknell DC, Wilding JL et al. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc Natl Acad Sci USA 2004; 101: 574-579.
14. Lynch J, Suh ER, Silberg DG, Rulyak S, Blanchard N, Traber PG et al. The caudalrelated homeodomain protein Cdx1 inhibits proliferation of intestinal epithelial cells by down-regulation of D-type cyclins. J Biol Chem 2000; 275: 4499-4506.
15. Lynch J, Keller M, Guo RJ, Yang D, Traber P. Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expression. Oncogene 2003; 22: 6395-6407.
16. Guo RJ, Huang E, Ezaki T, Patel N, Sinclair K, Wu J et al. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity. J Biol Chem 2004; 279: 36865-36875.
17. Crissey MA, Guo RJ, Fogt F, Li H, Katz JP, Silberg DG et al. The homeodomain transcription factor Cdx1 does not behave as an oncogene in normal mouse intestine. Neoplasia 2008; 10: 8-19.
18. Soubeyran P, Haglund K, Garcia S, Barth BU, Iovanna J, Dikic I et al. Homeobox gene Cdx1 regulates Ras, Rho and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells. Oncogene 2001; 20: 4180-4187.
19. Silberg DG, Furth EE, Taylor JK, Schuck T, Chiou T, Traber PG et al. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 1997; 113: 478-486.
20. Boussioutas A, Li H, Liu J, Waring P, Lade S, Holloway AJ et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 2003; 63: 2569-2577.
21. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
22. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-286.
23. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-379.
24. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009; 137: 647-658.
25. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY et al. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
26. Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68: 8164-8172.
27. Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, Zhao Q et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 2011; 20: 635-648.
28. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2010; 70: 5184-5193.
29. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011; 19: 232-243.
30. Wurdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14: 382-393.
31. Hong L, Han Y, Zhang H, Li M, Gong T, Sun L et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010; 251: 1056-1063.
32. Yoon AR, Gao R, Kaul Z, Choi IK, Ryu J, Noble JR et al. MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region. Nucleic Acids Res 2011; 39: 8078-8091.
33. Domon-Dell C, Schneider A, Moucadel V, Guerin E, Guenot D, Aguillon S et al. Cdx1 homeobox gene during human colon cancer progression. Oncogene 2003; 22: 7913-7921.
34. Soubeyran P, André F, Lissitzky JC, Mallo GV, Moucadel V, Roccabianca M et al. Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology 1999; 117: 1326-1338.
35. Wong NA, Wilding J, Bartlett S, Liu Y, Warren BF, Piris J et al. CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci USA 2005; 102: 7565-7570.
36. Kazumori H, Ishihara S, Kinoshita Y. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut 2009; 58: 620-628.
37. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-1700.
38. Zhao X, Dou W, He L, Liang S, Tie J, Liu C et al. MicroRNA-7 functions as an antimetastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2013; 32: 1363-1372.
39. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang X et al. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 2012; 31: 1398-1407.
40. Chaudhuri K, Chatterjee R. MicroRNA detection and target prediction: integration of computational and experimental approaches. DNA Cell Biol 2007; 26: 321-337.
41. Vaira V, Faversani A, Dohi T, Montorsi M, Augello C, Gatti S et al. miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 2012; 31: 27-38.
42. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
43. Meloche S, Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene 2007; 26: 3227-3239.
44. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995; 270: 23589-23597.
45. Lavoie JN, L'Allemain G, Brunet A, Mü ller R, Pouysségur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996; 271: 20608-20616.
46. Xu Y, Liu L, Qiu X, Liu Z, Li H, Li Z et al. CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells. PLoS One 2012; 7: e33262.
47. Pucci B, Indelicato M, Paradisi V, Reali V, Pellegrini L, Aventaggiato M et al. ERK-1 MAP kinase prevents TNF-induced apoptosis through bad phosphorylation and inhibition of Bax translocation in HeLa Cells. J Cell Biochem 2009; 108: 1166-1174.
48. Jeon SH, Yoon JY, Park YN, Jeong WJ, Kim S, Jho EH et al. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin. J Biol Chem 2007; 282: 14482-14492.